Biotech · Public company · Mclean, VA, US
Retension Pharmaceuticals, Inc.
Ticker RTSN · SEC CIK 0002002988
Track this companyFree. Adds Retension Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline1
- RTN-001Phase 2 · Uncontrolled HypertensionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- A Study of Modified Release RTN-001 In Patients With Uncontrolled HypertensionPHASE2 · RECRUITING · started Oct 31, 2025ClinicalTrials.gov NCT07142356 · fetched Nov 12, 2026
SEC filings6
- 8-K · CURRENT REPORTSEC EDGAR · filed Oct 23, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Oct 13, 2026 · fetched Nov 12, 2026
- 424B4 · PROSPECTUSSEC EDGAR · filed Oct 9, 2026 · fetched Nov 12, 2026
- S-1/A · REGISTRATION STATEMENTSEC EDGAR · filed Oct 7, 2026 · fetched Nov 12, 2026
- S-1/A · AMENDMENT NO. 1 TO FORM S-1SEC EDGAR · filed Oct 5, 2026 · fetched Nov 12, 2026
- S-1 · REGISTRATION STATEMENTSEC EDGAR · filed Sep 18, 2026 · fetched Nov 12, 2026